However, there are few reports on the role of PON1 activity in patients with asthma and COPD (10–12), and there are reports on its effect on lung cancer behavior and progression through antioxidant function and controlled ROS accumulation (13). The gene discussed is PON1; the disease is chronic obstructive pulmonary disease.